Sleep Apnea in the Cardiac Patient Stephen Jennison.

Slides:



Advertisements
Similar presentations
1 Mark Huffman, MD, MPH Northwestern University Feinberg School of Medicine Northwestern Memorial Hospital Healthy Transitions 21 November 2013 Blood Pressure.
Advertisements

Obesity Hypoventilation Syndrome
Sleep Apnea Sleep apnea is a sleep disorder that is characterized by pauses or decreased breathing lasting at least.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
Sleep Apnea and Cardiovascular Disease
OBSTRUCTIVE SLEEP-RELATED BREATHING DISORDERS IN ADULTS DR. MOHSEN PAZOOKI.
Valsartan Antihypertensive Long-Term Use Evaluation Results
Obstructive Sleep Apnea and Cardiovascular Disease: A Tale of Two Unhappy Bedfellows Najib Ayas MD MPH Associate Professor of Medicine Sleep Disorders.
TROPHY TRial Of Preventing HYpertension. High-normal BP increases CV risk Vasan RS et al. N Engl J Med. 2001;345: Incidence of CV events in women.
Martin Duke, MD, MRO February 20, Agenda What is OSA? Obstructive Sleep Apnea Cycle Steps in OSA Evaluation.
OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD Pediatric Pulmonology Unit, Sleep Disorders Laboratory First Department.
Early Identification of Obstructive Sleep Apnea and Prevention of Long Term Health Risks Becky Ellis, RN, BSN.
Stephan Eisenschenk, MD Department of Neurology SLEEP-RELATED BREATHING DISORDERS.
Raghu Upender, MD Assistant Professor in Neurology Medical Director Vanderbilt Sleep Disorders Center.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Obstructive Sleep Apnea: Is it in your Differential? Helene Hill Professor Sam Powdrill PAS 645.
September 11, 2012 Mike Hummel Watermark Medical Obstructive Sleep Apnea (OSA) Impacting Workplace Safety and Cost.
10th Meeting of the Mediterranean Group for the Study of Diabetes Istanbul – April 26-29, 2007 Lung dysfunctions in Metabolic Syndrome and Diabetes Prof.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
Obstructive Sleep Apnea of Obese Adults Obstructive Sleep Apnea of Obese Adults Pathophysiology and Perioperative Airway Management Anesthesiology, 2009,
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
OSA Pathogenesis, Co-morbidities and Outcomes John Reid, MD FRCP(C) RMGIM Conference, Banff November 24, 2012.
Dr. Atapour Nephrologist. Hypertension Blood pressure levels are a function of cardiac output multiplied by peripheral resistance (the resistance in.
Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.
Medical Grand Rounds Clinical Vignette March 11, 2009 By Melissa Price, M.D.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
Obstructive Sleep Apnea 442 Med Course Prepared by: Prof. Ahmed BaHammam.
The Change of Sympathetic Activity During Continuous Positive Airway Pressure Therapy in Obstructive Sleep Apnea Patients with and without Hypertension.
The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
Evaluating a Case of Sleep Apnoea Dr J.M. Joshi Professor and Head Department of Pulmonary Medicine T.N. Medical College B.Y.L. Nair Hospital Mumbai.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
2007 Hypertension as a Public Health Risk January, 2007.
THE SECRET LIFE OF SNORERS PRESENTED BY ^ Sex Content By: Snoring Isn’t Sexy, LLC.
Sleep Apnea and Cardiovascular Disease Randy A. Jordan, M.D. Interventional Cardiologist CMO-Jack Stephens Heart Institute CHI St. Vincent Heart Clinic.
Relationship Between Sleep and Obesity. Why We Need Sleep! A good night sleep is very important to a person’s overall health and their ability to function.
Amy S Jordan, David G McSharry, Atul Malhotra Lancet 2014; 383: 736–47.
Journal Club February 7, 2014 Sadie T. Velásquez, MD.
CPAP versus Oxygen in Obstructive Sleep Apnea Daniel J. Gottlieb, M.D., M.P.H., Naresh M. Punjabi, M.D., Ph.D., Reena Mehra, M.D., Sanjay R. Patel, M.D.,
Obstructive Sleep Apnea 441 Med Course Ahmed BaHammam.
T HREE STRIKES IS ENOUGH Karalyn J Huxhagen B Pharm FPS AACPA Cardiovascular Health Sleep Apnoea Diabetes.
11. Conclusion 10. Adherence to investigation 6. EDS by Epworth SS in OSA pts. (165) 6. EDS by Epworth SS in OSA pts. (165) 2. Suspicion of OSA in 210.
Date of download: 7/15/2016 Copyright © The American College of Cardiology. All rights reserved. From: Obstructive sleep apnea and cardiovascular disease.
Antonio Coca, MD, PhD, FRCP, FESC
Natsios Georgios University Hospital of Larissa, Greece
Prof. Dr. ABDUL HAMEED AL QASEER
Atrial Fibrillation and Obstructive Sleep Apnea
Hypertension November 2016
Hypertension guidelines What’s all the controversy about 2015
Obstructive Sleep Apnea
Blood Pressure and Age in Controlling Hypertension
Judith H. Veis, MD, FACP Associate Director, Nephrology
Sleep Apnea Treatment
All-cause mortality by treatment group
Κολπικη μαρμαρυγη σε ασθενεις με αποφρακτικη υπνικη απνοια
The Anglo Scandinavian Cardiac Outcomes Trial
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
SAVE Trial design: Patients with moderate to severe obstructive sleep apnea (OSA) and known CV disease were randomized in a 1:1 fashion to either CPAP.
Progress and Promise in RAAS Blockade
The Hypertension in the Very Elderly Trial (HYVET)
Approach to the true resistant hypertensive and treatment approaches
What It Is and Why It Matters
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Primary Hypertension Max C. Reif, M.D.
Department of Radiology
Hypertension November 2016
OVERVIEW OF SLEEP DISORDERED BREATHING (SDB)
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Stroke Prevention: An Evidence-Based Update
Presentation transcript:

Sleep Apnea in the Cardiac Patient Stephen Jennison

What is the impact of Sleep apnea on cardiovascular disease? Which came first: sleep apnea or CV disease?Which came first: sleep apnea or CV disease? More research is needed per AHA and ACCMore research is needed per AHA and ACC Difficult to decide impact due to multiple co-Difficult to decide impact due to multiple co- morbidities of obesity, diabetes and metabolic syndrome morbidities of obesity, diabetes and metabolic syndrome

SDB Impact on the Cardiovascular System Both OSA & CSA occur commonly in patients with cardiovascular disease and HF and may contribute to disease progression.Both OSA & CSA occur commonly in patients with cardiovascular disease and HF and may contribute to disease progression.

Sympathetic Activation Wakefulness Sleep Arousal & Hyperventilation O 2 & CO 2 Sympathetic Activation Airway Patency Compensation Airway Collapse Decreased Compensation O 2 & CO 2 Increased RR Increased mental activity Increased BP HR Increased Increased release of glucose

OSA Impacts: Sympathetic Nerve Activity, Blood Pressure, Oxygenation etc. OSA BP RESP Sympathetic Nerve Activity Somers VK et al. J Clin Invest. 1995;96:1897.

Studies Linking OSA and Cardiovascular Disease

Prevalence of Sleep Disordered Breathing in Cardiovascular Disease 30% of cardiac disease patients30% of cardiac disease patients –Schafer et al, Cardiology % of heart failure patients50% of heart failure patients –Javaheri, Circulation % pts with systolic HF40% pts with systolic HF 50% pts with diastolic HF50% pts with diastolic HF 30% of hypertensive patients30% of hypertensive patients –83% of refractory hypertension Logan et al, J Hypertension 2001Logan et al, J Hypertension 2001

40- 60% of patients with HTN have OSA % of patients with HTN have OSA 2 –85% of patients with Resistant Hypertension on 3 or more meds have OSA Even mild OSA is a risk factor for hypertension 3, 6Even mild OSA is a risk factor for hypertension 3, 6 Patients with untreated OSA may be resistant to their anti-hypertensive medications 4Patients with untreated OSA may be resistant to their anti-hypertensive medications 4 Even small decreases in blood pressure may help to decrease the risk of heart attack and stroke 5Even small decreases in blood pressure may help to decrease the risk of heart attack and stroke 5 ¹Silverberg, et al., Curr Hypertens R Kraicze, et al., AJRCCM Bixler, et al., Arch Intern Med Logan, et al., J Hypertens Heinrich, et al., Circulation Neito, et al., Jama 2000 Association Between OSA & Hypertension

New England Journal of Medicine, 2000 Peppard et al

Hypertension Guidelines Recommendation by Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7):Recommendation by Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7): –Sleep Apnea listed identifiable cause of Hypertension –All newly diagnosed patients should be screened for Sleep Apnea –All patients with refractory hypertension should be screened for Sleep Apnea Chobanian, AV et al., J Hypertens 2003; 42:

Association Between OSA & Heart Failure 37% of 450 HF patients had OSA37% of 450 HF patients had OSA –Also high incidence of Central or Mixed apneas Risk factors for OSA in HF includedRisk factors for OSA in HF included –BMI > 35 in males –Age > 60 in females Sin et.al, Am J Respir Crit Care Med 1999; 160: Work by Sin, et al., 2000

The prevalence of arrhythmias was compared in two samples of participants from the Sleep Heart Health StudyThe prevalence of arrhythmias was compared in two samples of participants from the Sleep Heart Health Study –228 subjects with sleep- disordered breathing (RDI > 30) vs. 338 subjects without sleep- disordered breathing (RDI 30) vs. 338 subjects without sleep- disordered breathing (RDI < 5) Individuals with severe sleep-disordered breathing have two to fourfold higher odds of complex arrhythmias than those without sleep-disordered breathing even after adjustment for potential confounders.Individuals with severe sleep-disordered breathing have two to fourfold higher odds of complex arrhythmias than those without sleep-disordered breathing even after adjustment for potential confounders. Association Between OSA & Arrhythmias Mehra R, et.al. Am J of Respir Crit Care Med 2006 Vol. 173: Shaded bar: pts with OSA White bar: pts. without OSA

ACC/AHA HFSA Heart Failure Guidelines Recommendation by American College of Cardiology, American Heart Association and the Heart Failure Society of America :Recommendation by American College of Cardiology, American Heart Association and the Heart Failure Society of America : –Sleep Apnea listed identifiable cause of Heart Failure –It is recommended that all newly diagnosed patients be screened for Sleep Apnea –Patients refractory to treatment for Heart Failure should be screened for Sleep Apnea Hunt, et.al. ACC/AHA 2005 Guidelines: Circulation:2005:112

The Impact of Untreated OSA on Cardiovascular System

Cardiovascular mortality and morbidity in OSA Study of 1651 Men, over 10 yearsStudy of 1651 Men, over 10 years –264 Normal (control group) –377 Snorers (AHI<5) –403 Untreated Mild-Mod OSA (AHI 5 – 30 without EDS) –235 Untreated Severe OSA (AHI > 30 or AHI> 5 with EDS) –372 Severe OSA with CPAP Treatment OSA (AHI > 30, CPAP > 4hrs/day) CPAP compliance objectively measuredCPAP compliance objectively measured Study Fatal and Non-Fatal Cardiac EventsStudy Fatal and Non-Fatal Cardiac Events Marin, JM et. al Lancet 2005: 365:

Fatal CV Events over 10 year period Marin, JM et. al Lancet 2005: 365:

Non-Fatal CV Events per group Marin, JM et. al Lancet 2005: 365:

Outcomes of Study Patients with severe OSA that was left untreated had a significant increase in CV events (both fatal or non-fatal events) after 10 yearsPatients with severe OSA that was left untreated had a significant increase in CV events (both fatal or non-fatal events) after 10 years –Risk factor: 2.87 higher than norms Patients with severe OSA had a significant reduction in CV events when treated with CPAPPatients with severe OSA had a significant reduction in CV events when treated with CPAP –Patients who used CPAP > 4 hours per night had a drop in CV risk Marin, JM et. al Lancet 2005: 365:

Treatment of OSA & Refractory HTN 16 of 19 refractory HTN patients had underlying OSA16 of 19 refractory HTN patients had underlying OSA 11 patients participated in CPAP trial11 patients participated in CPAP trial CPAP titrated to approx. 9 cm H 2 0CPAP titrated to approx. 9 cm H 2 0 Blood pressure and baroreflex sensitivity were studied on and off CPAPBlood pressure and baroreflex sensitivity were studied on and off CPAP 24-hour blood pressure was evaluated at baseline and after 2 months of CPAP therapy24-hour blood pressure was evaluated at baseline and after 2 months of CPAP therapy Logan AG., et al., Eur Respir J 2003; 21: Logan AG., et al., Eur Respir J 2003; 21:

Results: CPAP group: Approximate 10mmHg drop in mean blood pressureCPAP group: Approximate 10mmHg drop in mean blood pressure –predicts a 37% reduction in risk for CHD –56% reduction in risk for stroke No relevant change in blood pressure occurred with sub- therapeutic CPAPNo relevant change in blood pressure occurred with sub- therapeutic CPAP

Screening in Hospital Sleep apnea is found in at least 50% of patients with CHFSleep apnea is found in at least 50% of patients with CHF Heart Failure nurses should screen for sleep apnea in all CHF patientsHeart Failure nurses should screen for sleep apnea in all CHF patients Referral to sleep disorder teamReferral to sleep disorder team Outpatient sleep study per MD orderOutpatient sleep study per MD order All cardiac patients in outpatient Cardiology clinic should be screened with Epworth Sleepiness tool

Results: Treatment of OSA & Refractory HTN PopulationPre-CPAP On CPAP p value AHI (hr -1 sleep) 45.3± ±0.5<0.01 Arousal Index (hr -1 sleep) 37.1±5.99.4±1.6<0.001 Lowest SaO 2 (%) 83.3± ±0.7< Logan AG., et al., Eur Respir J 2003; 21:

Hallmark OSA Signs and Symptoms Excessive daytime sleepiness (EDS) unexplained by other factorsExcessive daytime sleepiness (EDS) unexplained by other factors with with Loud disruptive snoringLoud disruptive snoring or or Nocturnal choking/gasping/snortingNocturnal choking/gasping/snorting or or Nocturnal pauses in breathingNocturnal pauses in breathing

Additional Signs/Symptoms of OSA Recurrent nocturnal awakeningsRecurrent nocturnal awakenings Un-refreshing sleepUn-refreshing sleep Daytime fatigueDaytime fatigue Impaired concentration/memory lossImpaired concentration/memory loss Mood/behavioral changesMood/behavioral changes Morning headachesMorning headaches Loss of sexual interestLoss of sexual interest

Pearls If person is on 3 antihypertensive medications and still has high blood pressure, consider a sleep studyIf person is on 3 antihypertensive medications and still has high blood pressure, consider a sleep study When a person has “congestive heart failure” due to fluid buildup and their BNP is less than 120, screen for sleep apneaWhen a person has “congestive heart failure” due to fluid buildup and their BNP is less than 120, screen for sleep apnea Newly diagnosed CHF patients should be screened for sleep apnea earlyNewly diagnosed CHF patients should be screened for sleep apnea early Atrial fibrillation patients should be screenedAtrial fibrillation patients should be screened All cardiac patients should be screened when no other known cause for cardiac conditionAll cardiac patients should be screened when no other known cause for cardiac condition

Suggestions for cardiac patients to use CPAP/ BIPAP Use humidifier on CPAP to prevent drynessUse humidifier on CPAP to prevent dryness Nasal spray to open air passagesNasal spray to open air passages Wear during naps to get used to mask and get a boost of energy for rest of the dayWear during naps to get used to mask and get a boost of energy for rest of the day Encourage support from spouse/SOEncourage support from spouse/SO Give CPAP a friendly nameGive CPAP a friendly name Use at least 4 hours per night for benefitUse at least 4 hours per night for benefit

Great News Treatment can give people a new lease on lifeTreatment can give people a new lease on life More energyMore energy Relieve headachesRelieve headaches Control blood pressureControl blood pressure Sleep all nightSleep all night Less strain on the heartLess strain on the heart Reduces cardiac eventsReduces cardiac events Improve CHF symptomsImprove CHF symptoms

Sleep Trivia on Internet sites 3,150,000 sites for sleep apnea3,150,000 sites for sleep apnea Oral Appliances that mold to your mouthOral Appliances that mold to your mouth Exercises to “cure” sleep apnea $19.99Exercises to “cure” sleep apnea $19.99

Sleep tight